BioMarin drops 17% after Ascendis data seen as threat to Voxzogo by Technical Terrence Team 09/16/2024 0 hapabapa/iStock Editorial via Getty Images BioMarin Pharmaceuticals (NASDAQ:BMRN) is Down ~17% On Monday, it became known that an achondroplasia candidate ...